Gene · 4070
Papers3,230
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
841 to 860 of 3,230
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Antibody Banding Patterns on the Enzyme-Linked Immunoelectrotransfer Blot (EITB) Assay Clearly Discriminate Viable Cysticercosis in Naturally Infected Pigs. | Pathogens | 2023 | 38251323 | PubTator, text mining | PubMed |
| Phylogenetic conservation of Trop-2 across species-rodent and primate genomics model anti-Trop-2 therapy for pre-clinical benchmarks. | Front Genet | 2023 | 38250577 | PubTator, text mining | PubMed |
| Current status and future perspective of natural killer cell therapy for cancer. | Med Rev (2021) | 2023 | 38235405 | PubTator, text mining | PubMed |
| Facing the conundrum: which first-line therapy should be used for patients with metastatic triple-negative breast cancer carrying germline BRCA mutation? | Explor Target Antitumor Ther | 2023 | 38213539 | PubTator, text mining | PubMed |
| Targeting cancer stem cell plasticity in triple-negative breast cancer. | Explor Target Antitumor Ther | 2023 | 38213533 | PubTator, text mining | PubMed |
| Actionable Driver Events in Small Cell Lung Cancer. | Int J Mol Sci | 2023 | 38203275 | PubTator, text mining | PubMed |
| The Relationship between Trop-2, Chemotherapeutic Drugs, and Chemoresistance. | Int J Mol Sci | 2023 | 38203255 | PubTator, text mining | PubMed |
| Precision Immunotherapy Utilizing Adapter CAR-T Cells (AdCAR-T) in Metastatic Breast Cancer Leads to Target Specific Lysis. | Cancers (Basel) | 2023 | 38201595 | PubTator, text mining | PubMed |
| Exploiting the DNA Damage Response for Prostate Cancer Therapy. | Cancers (Basel) | 2023 | 38201511 | PubTator, text mining | PubMed |
| Desmoglein-2 as a cancer modulator: friend or foe? | Front Oncol | 2023 | 38188287 | PubTator, text mining | PubMed |
| A tumor-restricted glycoform of podocalyxin is a highly selective marker of immunologically cold high-grade serous ovarian carcinoma. | Front Oncol | 2023 | 38188285 | PubTator, text mining | PubMed |
| Targeting Trop2 in solid tumors: a look into structures and novel epitopes. | Front Immunol | 2023 | 38179054 | PubTator, text mining | PubMed |
| Trop-2 as an Actionable Biomarker in Breast Cancer. | Curr Genomics | 2023 | 38178982 | PubTator, text mining | PubMed |
| Corrigendum: Preclinical profiles of SKB264, a novel anti-TROP2 antibody conjugated to topoisomerase inhibitor, demonstrated promising antitumor efficacy compared to IMMU-132. | Front Oncol | 2023 | 38173839 | PubTator, text mining | PubMed |
| Antibody-drug conjugates in urinary tumors: clinical application, challenge, and perspectives. | Front Oncol | 2023 | 38173833 | PubTator, text mining | PubMed |
| The clinical development of antibody-drug conjugates for non-small cell lung cancer therapy. | Front Immunol | 2023 | 38162667 | PubTator, text mining | PubMed |
| CAR-T cell immunotherapy for ovarian cancer: hushing the silent killer. | Front Immunol | 2023 | 38146364 | PubTator, text mining | PubMed |
| Special Issue: Evaluation of the Antitumor Mechanism of Armed Antibodies. | Pharmaceuticals (Basel) | 2023 | 38139816 | PubTator, text mining | PubMed |
| Advances in Diagnostic Tools and Therapeutic Approaches for Gliomas: A Comprehensive Review. | Sensors (Basel) | 2023 | 38139688 | PubTator, text mining | PubMed |
| Generation and Characterization of SORT1-Targeted Antibody-Drug Conjugate for the Treatment of SORT1-Positive Breast Tumor. | Int J Mol Sci | 2023 | 38139459 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4070/papers?page=43